At Intervacc, we believe it is urgent to develop better vaccines to prevent the spread of the infectious diseases of today and tomorrow. We believe in the vison of One Health and that in order to create a healthier world we need to look at the system as a whole to fight existing and new infectious diseases in animals as well as in humans. We need to combat zoonotic diseases and we need to slow down the development of antibiotic resistant bacteria. We are dedicated to developing safe, effective and practical vaccines within animal health, and to bring these vaccines to the global market. This is our passion and our mission.
We have an exciting new opportunity for a Global Product Manager for our lead product Strangvac - a vaccine that promises to be a game changer in the fight against the equine disease Strangles.
Strangvac is expected to be launched commercially in Europe during the summer of 2021. As Global Product Manager, you will have the overall strategic responsibility of successfully launching Strangvac as well as the further development of Intervacc’s equine portfolio. You will collaborate closely with both internal and external stakeholders in our overall mission to provide this safe, efficacious and easy-to-administer equine vaccine to the global market.
Intervacc has its HQ in Stockholm Sweden and is listed on the Swedish Nasdaq First North Growth Market. The position is preferably based in Stockholm Sweden, but for the right candidate it is also possible to work from a home office for example located in the UK, France, Germany, or Benelux. We welcome your application today!
As a Global Product Manager, you will lead the task of launching Strangvac around the world.
Duties and responsibilities include:
•Lead the global launch of the strangles vaccine Strangvac for Intervacc
•Lead the marketing campaign for Strangvac
•Together with our R&D team, lead the further development of the equine portfolio
•Support and strengthen our local product specialist team
•Support the European distribution partner for Strangvac and help build the global distribution partner network for the global launch of Strangvac
•Build strategic and cross-functional collaborations, both internal and external, to secure the long-term profitability of Strangvac and the equine portfolio
•Participate in bringing in new competencies and talents to Intervacc and continue to grow the team.
SKILLS AND COMPETENCIES
The suitable candidate has the following qualifications:
•Strong interest in, and understanding of the equine market
•Excellent B2B skill set
•Experience in working with big pharma
•University degree in relevant discipline, such as veterinary medicine (merited, but not required), biomedicine, pharmacy, equine studies
•Marketing knowledge in the veterinary equine segment is a merit
•Preferable working experience as Product Manager or Equine Specialist from the Animal Health Sector or as a Product manager in the Pharmaceutical Human Health Sector
•English language working proficiency required
•Swedish language working proficiency a plus, but not required
The ideal candidate for this position has a passion for equine medicine and thrives in a role that requires both operational management and strategic overview. Strong communication and time management skills as well as a high level of accountability are required to be successful in this role. Furthermore, we believe that you are a real team player, “quick on your feet” and have an eye for details. Importantly, you are a person who can enjoy the benefits of working in a smaller organization with dedicated, highly skilled, and knowledgeable colleagues, but also interact with large global partners with ease.
Intervacc is already one of the most exciting biotech companies in Sweden and unique in its position of being mid-way through the regulatory process of receiving a central EMA approval for a new vaccine with a large unmet medical need. If you are ready to bring your passion, experience, and expertise, we are ready to offer you a unique opportunity to have a key role at an innovative company with an exciting journey ahead!
Intervacc is a Swedish biotechnology company specialized in vaccine development within Animal Health and has its own sales and distribution business in Scandinavia and the Baltics. We develop veterinary vaccines based on fusions of recombinant proteins together with the world leading scientific expertise from the Karolinska Institute and the Swedish University of Agricultural Sciences. The Intervacc share (STO: IVACC) is listed on the NASDAQ First North Growth Market. Our headquarter is in Stockholm, Sweden and we have local offices in Copenhagen (DK), Riga (LV) and New Market (UK). You can find more information about Intervacc at www.intervacc.com
To apply for this position press the ”ANSÖK NU” button and follow the instructions.